|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.9 USD | +4.70% |
|
+4.59% | +5.60% |
| 03:44pm | Sector Update: Financial Stocks Steady Premarket Friday | MT |
| 02:04pm | T Rowe's quarterly profit beats estimates on tailwinds from market rally | RE |
On April 19, 2022, Sionna Therapeutics closed the transaction. The company announced that it has received $111,000,000 in a round of funding led by new investor OrbiMed Advisors LLC. The transaction included participation from new investors T. Rowe Price Group, Inc., Q Healthcare Holding Llc, existing investors RA Capital Management, L.P., TPG The Rise Fund, TPG Capital, L.P., Atlas Venture L.P., and Cystic Fibrosis Foundation.
The company has raised $150,000,000 in funding till date.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.60% | 24.34B | |
| -5.94% | 113B | |
| -3.98% | 87.7B | |
| +20.96% | 63.57B | |
| +5.16% | 60.75B | |
| +10.25% | 42.76B | |
| +8.15% | 40.93B | |
| +18.92% | 34.26B | |
| -5.14% | 22.1B | |
| +0.52% | 19.06B |
T. ROWE PRICE GROUP INC. 
